Table 4.
Relative 5-year survival rates for patients with invasive cancer: Hoag and national SEER data for different time periods
| Hoag Relative 5-Year Survival (%) | SEER Relative 5-Year Survival (%) | Hoag Relative 5-year Survival (%) | SEER Relative 5-Year Survival (%) | |
|---|---|---|---|---|
| 1986-1991 | 1986-1991 | 1992-1999 | 1992-1999 | |
| Breast | 89 | 84 | 95 | 88 |
| Colon | 66 | 62 | 72 | 63 |
| Rectal | 68 | 60 | 83 | 62 |
| Esophagus | 3 | 11 | 15 | 15 |
| Liver | 4 | 11 | 15 | 7 |
| Melanoma | 86 | 87 | 92 | 90 |
| Pancreas | 0 | 3 | 7 | 4 |
| Stomach | 12 | 19 | 29 | 21 |
| Thyroid | 90 | 95 | 98 | 96 |
| Cervix | 70 | 71 | 76 | 73 |
| Uterus | 90 | 85 | 89 | 86 |
| Ovary | 39 | 44 | 57 | 52 |
| Bladder | 78 | 82 | 87 | 83 |
| Kidney | 64 | 59 | 66 | 63 |
| Prostate | 92 | 87 | 100 | 98 |
| Testis | 88 | 95 | 99 | 96 |
| Lung | 20 | 14 | 24 | 15 |
| Larynx | 83 | 68 | 85 | 67 |
| Oral cavity | 58 | 55 | 67 | 60 |
| Brain | 25 | 28 | 26 | 32 |
| Hodgkin's | 92 | 81 | 84 | 85 |
| Leukemia | 24 | 41 | 45 | 48 |
| Lymphoma | 55 | 52 | 59 | 57 |
| Myeloma | 30 | 28 | 38 | 31 |
| All patients | 63 | 58 | 71 | 64 |
*
Excludes in situ cancer, except for bladder cancer; includes unknown stage at diagnosis, and other less common tumor types that are not listed in the table; so columns do not add up to the numbers on the bottom line.